Last updated: October 04, 2026

Application No. 18/485,224

INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF

Non-Final OA

Filed

Oct 11, 2023

Priority

Oct 12, 2022 — provisional 63/415,590 +2 more

Examiner

ROMERO, KRISTEN WANG

Art Unit

1624

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Maze Therapeutics Inc.

OA Round

2 (Non-Final)

Interview Optional

— +31.9% interview lift. Examiner has a relatively high allowance rate (69%); +31.9% interview lift. A written response may suffice.

Based on 48 resolved cases, 2023–2026

Examiner Intelligence

ROMERO, KRISTEN WANG View full profile →

Grants 69% — above average

Career Allowance Rate

33 granted / 48 resolved

+8.8% vs TC avg

Strong +32% interview lift

Without

With

+31.9%

Interview Lift

resolved cases with interview

Typical timeline

3y 2m

Avg Prosecution

43 currently pending

Career history

Total Applications

across all art units

Statute-Specific Performance

§101

3.4%

-36.6% vs TC avg

§103

21.3%

-18.7% vs TC avg

§102

19.3%

-20.7% vs TC avg

§112

37.5%

-2.5% vs TC avg

Black line = Tech Center average estimate • Based on career data from 48 resolved cases

Prosecution Timeline

Oct 11, 2023

Application Filed

Mar 12, 2026

Non-Final Rejection mailed

Jun 12, 2026

Response Filed

Jul 28, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/123,096

Patent 12747229

PYRAZOLYL PYRIMIDINONE COMPOUNDS AND THE USES THEREOF

3y 6m to grant Granted Sep 29, 2026

18/321,325

Patent 12747217

PROCESS FOR THE MANUFACTURE OF TETRAZOLE DERIVATIVES

3y 4m to grant Granted Sep 29, 2026

18/259,458

Patent 12740993

CANNABINOIDS AND USES THEREOF FOR TREATMENT OF ESTROGEN RECEPTOR RELATED DISEASES

3y 2m to grant Granted Sep 22, 2026

18/421,544

Patent 12734148

METHOD FOR TREATING DIABETES BY USING ANTRODIA CAMPHORATA COMPOUND

2y 7m to grant Granted Sep 15, 2026

18/033,210

Patent 12729186

PRODRUGS FOR SUSTAINED RELEASING THERAPEUTIC AGENTS AND USES THEREOF

3y 4m to grant Granted Sep 08, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3

Expected OA Rounds

69%

Grant Probability

99%

With Interview (+31.9%)

3y 2m (~2m remaining)

Median Time to Grant

Moderate

PTA Risk

Based on 48 resolved cases by this examiner. Grant probability derived from career allowance rate.